Helius Medical Technologies is trading at $2.94, down 10.17%, amid broad market weakness on September 23, 2026, as rising crude oil and Treasury yields pressure risk assets. - Reuters reported Wall Street was set to open lower for those reasons. - The decline follows three consecutive advancing sessions totaling a substantial rebound; profit-taking may be amplifying the market-driven move. - The September 22 analyst price-target increase was bullish, not a direct explanation for today’s decline.